x
ServiziMenu principaleHome
Home > Sponsors & Exhibition > Sponsored satellite symposia
Print

Sponsored satellite symposia

Thursday, 2 November


AstraZeneca

9:00 -10:30 Sponsored satellite symposium 1 AstraZeneca

Illuminating a new pathway in breast cancer

09:00 The guiding light - meeting the needs of the patient
09:05 Welcome and introduction (Christian Jackisch, DE)
09:10 Highlighting a new target in breast cancer – DNA damage response (Cristina Cruz, ES)
09:25 Shining the light on a new breast cancer paradigm (Sibylle Loibl, DE)
09:35 Opportunity for questions (Chair: Christian Jackisch, DE)
09:45 PARP inhibitors - a spark for change in breast cancer management (Pierfranco Conte, IT)
10:05 In the spotlight - the use of BRCA in clinical practice (Panel discussion - Chair: Sibylle Loibl, DE)
10:15 Opportunity for questions (Chair: Christian Jackisch, DE)
10:25 Summary and close (Christian Jackisch, DE)

Symposium faculty
Cristina Cruz, Institute of Oncology, Barcelona, Spain
Pierfranco Conte, Istituto Oncologico Veneto, Padova, Italy
Christian Jackisch, Sana Klinikum Offenbach, Offenbach, Germany
Sibylle Loibl, German Breast Group, Neu-Isenburg, Frankfurt, Germany


Novartis

11:00 -12:30 Sponsored satellite symposium 2 Novartis

Patient-centric treatment decisions in clinical practice: Harnessing the power of combination therapy
Chair: Diana Lüftner, DE

11:00 Joining forces for efficacy: The current state of targeted therapy for HR+, HER2– advanced breast cancer
         (Chair: Diana Lüftner, DE - Speaker: Luis Costa, PT)
11:15 Patterns, combinations, and sequences: Case-based discussion on treatment decisions for HR+, HER2– advanced breast cancer
         (Case Presenter and Moderator: Diana Lüftner, DE - Panelists: Luis Costa, PT - Guenther Steger, AT)
12:10 Q & A discussion (Moderator: Guenther Steger, AT)
12:20 Forging future understandings (Speaker: Luis Costa, PT)

Symposium faculty
Luis Costa, Hospital Santa Maria, Lisbon, Portugal
Diana Lüftner, Humboldt University, Berlin, Germany
Guenther Steger, Medical University of Vienna, Vienna, Austria


Pfizer Oncology18:00 -19:30 Sponsored satellite symposium 3 Pfizer Oncology

A united vision for mBC: changing the treatment paradigm with CDK4/6 inhibitors
Chair: Antonio Llombart-Cussac, ES

18:00 Welcome and introduction (Antonio Llombart-Cussac, ES)
18:05 A united vision: guiding principles in the management of breast cancer (Günther Steger, AT)
18:25 Challenging current perceptions in HR+/HER2– mBC (Antonio Llombart-Cussac, ES)
18:50 A glimpse into the therapy management of CDK4/6 inhibitors (Johannes Ettl, DE)
19:15 Panel discussion and Q&A (All faculty)
19:25 Closing remarks (Antonio Llombart-Cussac, ES)

Symposium faculty
Johannes Ettl, Technical University of Munich, Munich, Germany
Antonio Llombart-Cussac, University Hospital Arnau de Vilanova, Valencia, Spain

 

Friday, 3 November


Celgene18:00 -19:30 Sponsored satellite symposium 4 Celgene

The evolving sequence of therapies, moving forward in mBC: All chemotherapies are not created equally
Chair: Grazia Arpino, IT

18:00 Welcome and objectives (Grazia Arpino, IT)

18:05 Interactive patient case series: Improving how we manage patients with mBC (Marina Cazzaniga, IT - Eva Ciruelos, ES - Frederik Marme, DE)

  • Indolent mBC: Are we making optimal use of all our treatment options?
  • Rapidly progressive mBC: Identifying the correct treatment sequence in these challenging patients
  • Treating triple negative mBC: Clinical considerations for the use of Abraxane

19:05 Improving disease outcomes in patients with mBC: Choosing the right algorithm (Panel and audience discussion of the patient case study series)
19:25 Summary and close (Grazia Arpino, IT)

Symposium faculty
Grazia Arpino, University of Naples Federico II, Italy
Marina Cazzaniga, San Gerardo Hospital, Monza, Italy
Eva Ciruelos, University Hospital 12 de Octubre, Madrid, Spain
Frederik Marme, Universität Heidelberg, Heidelberg, Germany